Literature DB >> 14993106

Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons.

Judy L Morris1, Daina I Ozols, Richard J Lewis, Ian L Gibbins, Phillip Jobling.   

Abstract

1. The effects of calcium channel blockers on co-transmission from different populations of autonomic vasomotor neurons were studied on isolated segments of uterine artery and vena cava from guinea-pigs. 2. Sympathetic, noradrenergic contractions of the uterine artery (produced by 200 pulses at 1 or 10 Hz; 600 pulses at 20 Hz) were abolished by the N-type calcium channel blocker omega-conotoxin (CTX) GVIA at 1-10 nm. 3. Biphasic sympathetic contractions of the vena cava (600 pulses at 20 Hz) mediated by noradrenaline and neuropeptide Y were abolished by 10 nm CTX GVIA. 4. Neurogenic relaxations of the uterine artery (200 pulses at 10 Hz) mediated by neuronal nitric oxide and neuropeptides were reduced <50% by CTX GVIA 10-100 nm. 5. Capsaicin (3 microm) did not affect the CTX GVIA-sensitive or CTX GVIA-resistant neurogenic relaxations of the uterine artery. 6. The novel N-type blocker CTX CVID (100-300 nm), P/Q-type blockers agatoxin IVA (10-100 nm) or CTX CVIB (100 nm), the L-type blocker nifedipine (10 microm) or the 'R-type' blocker SNX-482 (100 nm), all failed to reduce CTX GVIA-resistant relaxations. The T-type channel blocker NiCl(2) (100-300 microm) reduced but did not abolish the remaining neurogenic dilations. 7. Release of different neurotransmitters from the same autonomic vasomotor axon depends on similar subtypes of calcium channels. N-type channels are responsible for transmitter release from vasoconstrictor neurons innervating a muscular artery and capacitance vein, but only partly mediate release of nitric oxide and neuropeptides from pelvic vasodilator neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993106      PMCID: PMC1574280          DOI: 10.1038/sj.bjp.0705712

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Effects of calcium antagonists on the nitrergic nerve function in canine corpus cavernosum.

Authors:  T Okamura; H Fujioka; K Ayajiki
Journal:  Jpn J Pharmacol       Date:  2001-11

Review 2.  Molecular physiology of low-voltage-activated t-type calcium channels.

Authors:  Edward Perez-Reyes
Journal:  Physiol Rev       Date:  2003-01       Impact factor: 37.312

3.  Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals.

Authors:  David J Adams; Amanda B Smith; Christina I Schroeder; Takahiro Yasuda; Richard J Lewis
Journal:  J Biol Chem       Date:  2002-11-18       Impact factor: 5.157

4.  Involvement of T-type calcium channels in excitatory junction potentials in rat resistance mesenteric arteries.

Authors:  Qi Xi; James Ziogas; Jonathan A Roberts; Richard J Evans; James A Angus
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications.

Authors:  J M Lundberg; T Hökfelt
Journal:  Prog Brain Res       Date:  1986       Impact factor: 2.453

6.  Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons.

Authors:  Judy L Morris; Phillip Jobling; Ian L Gibbins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08-29       Impact factor: 4.733

7.  The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices.

Authors:  Maree T Smith; Peter J Cabot; Fraser B Ross; Alan D Robertson; Richard J Lewis
Journal:  Pain       Date:  2002-03       Impact factor: 6.961

8.  Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations.

Authors:  J L Morris; R Murphy
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

9.  Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat.

Authors:  David A Scott; Christine E Wright; James A Angus
Journal:  Eur J Pharmacol       Date:  2002-09-20       Impact factor: 4.432

10.  Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones.

Authors:  A P Fox; M C Nowycky; R W Tsien
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

View more
  2 in total

Review 1.  Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.

Authors:  Terrance P Snutch
Journal:  NeuroRx       Date:  2005-10

2.  Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons.

Authors:  Mohamed A Motagally; Mark K Lukewich; Susan P Chisholm; Shadia Neshat; Alan E Lomax
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.